Published in
Elsevier, Atherosclerosis, 1(219), p. 109-115, 2011
DOI: 10.1016/j.atherosclerosis.2011.07.023
Links
- ORCID
- Elsevier
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
Journal article published in 2011 by
Kristina Duwensee,
Stefan Schwaiger,
Ivan Tancevski,
Kathrin Eller,
Miranda van Eck,
Patrick Markt,
Tobias Linder,
Ursula Stanzl,
Andreas Ritsch,
Josef R. Patsch,
Daniela Schuster 
,
Hermann Stuppner,
David Bernhard,
Philipp Eller
,
Hermann Stuppner,
David Bernhard,
Philipp Eller
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
► Leoligin significantly activated CETP in human plasma at 100 pM. ► Leoligin concentrations of 1 mM inhibited CETP activity. ► There was no short-term toxicity apparent in mice treated with leoligin.